These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6800185)

  • 1. A new familial defect of platelet release mechanism (the intracellular Ca++ transport defect?).
    Hattori A; Takahashi H; Takahashi M; Shibata A; Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):969-72. PubMed ID: 6800185
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on platelets in a patient with a novel hereditary platelet function disorder--impaired aggregation in response to A 23187 with normal response to arachidonic acid].
    Sugiyama T; Okuma M; Ushikubi F; Kanaji K; Sensaki S; Uchino H; Hattori A; Ihzumi T
    Rinsho Ketsueki; 1986 Oct; 27(10):1834-42. PubMed ID: 3102812
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
    Okuma M; Kanaji K; Sensaki S; Uchino H
    Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A morphological study on a familial release mechanism abnormality characterized by defective A23187-induced aggregation.
    Hattori A; Ihzumi T
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1155-67. PubMed ID: 7331688
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid metabolism of the platelet and platelet function (author's transl)].
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1976 Oct; 39(5):682-93. PubMed ID: 1037350
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.
    Machin SJ; Keenan JP; McVerry BA
    J Clin Pathol; 1983 Oct; 36(10):1140-4. PubMed ID: 6413552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital disorders of platelet function.
    Rao AK; Holmsen H
    Semin Hematol; 1986 Apr; 23(2):102-18. PubMed ID: 3010468
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic defects of prostaglandin and thromboxane synthesis].
    Schrör K
    Wien Klin Wochenschr; 1985 Jan; 97(2):64-70. PubMed ID: 3920834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Paeonia obovata 801 on metabolism of thromboxane B2 and arachidonic acid and on platelet aggregation in patients with coronary heart disease and cerebral thrombosis].
    Liu J
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):477-81. PubMed ID: 6418338
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aspirin-like defect - a hereditary thrombocytopathy due to impaired release of platelet adenosine diphosphate].
    Elezović I; Mijović A; Rolović Z
    Bilt Hematol Transfuz; 1979; 7(2-3):165-74. PubMed ID: 263623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of TEI-2117, a new antithrombotic compound, on arachidonic acid metabolism].
    Otsu A; Hoshina K; Kurozumi S; Hashimoto Y; Ishimoto S
    Rinsho Byori; 1979; Suppl 40():117-21. PubMed ID: 551219
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormalities of the platelet release mechanism with special reference to alterations in the arachidonate metabolism by human platelets (author's transl)].
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):1004-11. PubMed ID: 104518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arachidonic acid metabolism in platelets].
    Harada Y; Katori M
    Rinsho Byori; 1985 Jul; 33(7):722-5. PubMed ID: 4068260
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion.
    Feinstein MG; Fiekers J; Fraser C
    J Pharmacol Exp Ther; 1976 Apr; 197(1):215-28. PubMed ID: 772186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular regulation of the metabolism of arachidonic acid in human platelets.
    Bills TK; Smith JB; Silver MJ
    Thromb Haemost; 1978 Oct; 40(2):219-23. PubMed ID: 216129
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel eicosanoids generated by cytochrome P450: effects on platelet aggregation and protein phosphorylation.
    Malcolm K; Falck JR; Fitzpatrick FA
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():87-94. PubMed ID: 2144702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.